Phosphorus Dendrimers as Nanotools against Cancers

Area of Science:

• Nanotechnology in Medicine
• Oncology
• Materials Science

Background:

• Dendrimers are highly branched macromolecules with tunable properties.
• Phosphorhydrazone dendrimers represent a specific class with emerging applications in cancer therapy.

Purpose of the Study:

• To review the multifaceted roles of dendrimers, particularly phosphorhydrazone dendrimers, in combating cancer.
• To explore dendrimers as therapeutic agents, drug delivery systems, and inducers of cancer cell death.

Main Methods:

• Review of existing literature on dendrimer applications in oncology.
• Categorization of dendrimer functions: direct cytotoxicity, drug/siRNA delivery, and indirect cancer cell death induction.
• Analysis of surface-functionalized dendrimers with organic derivatives or metal complexes.

Main Results:

• Dendrimers can be designed as standalone anticancer drugs, functionalized with organic moieties or metal complexes.
• They serve as effective carriers for small molecule drugs and anticancer small interfering RNAs (siRNAs).
• Certain phosphorhydrazone dendrimers induce cancer cell death indirectly via immune system modulation or combined bioimaging/photodynamic therapy.

Conclusions:

• Phosphorhydrazone dendrimers offer diverse strategies for cancer treatment.
• Their versatility in direct action, drug delivery, and indirect cytotoxicity highlights their therapeutic potential.
• Future research should focus on optimizing these nanostructures for enhanced clinical efficacy.